Diabetes Education Certification Pregnancy & Gestational Diabetes 2

Question 1

Which glucose monitoring approach is strongly recommended for women with type 1 diabetes during pregnancy?

Accepted Answer

Continuous glucose monitoring (CGM)

Answer

CGM is strongly recommended in type 1 diabetes during pregnancy because it reduces A1C, hypoglycemia, and large-for-gestational-age births.

Question 2

What is the ADA-recommended A1C target during pregnancy for women with preexisting diabetes (when achievable without significant hypoglycemia)?

Accepted Answer

<6.5%

Answer

ADA recommends an A1C <6.5% during pregnancy for women with preexisting diabetes when achievable without clinically significant hypoglycemia.

Question 3

Which oral antidiabetic agent is most studied and sometimes used in pregnancy for GDM when insulin is not accepted by the patient?

Accepted Answer

Metformin

Answer

Metformin has the most pregnancy safety data among oral agents and may be used when insulin is refused, though insulin remains the preferred pharmacotherapy.

Question 4

What neonatal complication must be monitored for immediately after delivery in infants born to mothers with poorly controlled GDM?

Accepted Answer

Neonatal hypoglycemia

Answer

Fetal hyperinsulinemia persists after birth; once the maternal glucose supply is cut, continued insulin secretion causes neonatal hypoglycemia.

Question 5

At what postpartum time frame should women who had GDM be retested for persistent diabetes or prediabetes?

Accepted Answer

4–12 weeks postpartum

Answer

ADA recommends retesting at 4–12 weeks postpartum with a 75g OGTT to identify women who have persistent dysglycemia after GDM.

Diabetes Practice Test

Diabetes Practice Test

Diabetes Education Certification Pregnancy & Gestational Diabetes 2